GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Emergent Health Corp (OTCPK:EMGE) » Definitions » Beneish M-Score

Emergent Health (Emergent Health) Beneish M-Score


View and export this data going back to 2007. Start your Free Trial

What is Emergent Health Beneish M-Score?

Emergent Health does not have enough data to calculate Beneish M-Score.

Emergent Health Beneish M-Score Historical Data

The historical data trend for Emergent Health's Beneish M-Score can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Emergent Health Beneish M-Score Chart

Emergent Health Annual Data
Trend
Beneish M-Score

Emergent Health Quarterly Data
Beneish M-Score

Competitive Comparison of Emergent Health's Beneish M-Score

For the Drug Manufacturers - Specialty & Generic subindustry, Emergent Health's Beneish M-Score, along with its competitors' market caps and Beneish M-Score data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Emergent Health's Beneish M-Score Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Emergent Health's Beneish M-Score distribution charts can be found below:

* The bar in red indicates where Emergent Health's Beneish M-Score falls into.


Emergent Health Beneish M-Score Related Terms

Thank you for viewing the detailed overview of Emergent Health's Beneish M-Score provided by GuruFocus.com. Please click on the following links to see related term pages.

Emergent Health (Emergent Health) Business Description

Industry
GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Emergent Health Corp (OTCPK:EMGE) » Definitions » Beneish M-Score
Comparable Companies
BIEI BOM:524516 TSXV:CIP.H BOM:531686 PTXTQ BOM:524606 XCNQ:WRW NSE:PARABDRUGS BOM:533157 INQD XCNQ:CANA BOM:524314 ACCA BOM:511523 BOM:531541 XCNQ:WLLW BKIT BOM:524768 BOM:540359 BOM:524632
Traded in Other Exchanges
N/A
Address
519 8th Avenue, 25th Floor, New York, NY, USA, 10018
Website
https://www.emergenthealthcompany.com
Emergent Health Corp manufactures and sells vitamin products to retail customers across the United States of America.

Emergent Health (Emergent Health) Headlines

From GuruFocus

Emergent and Proposed Acquisition Partner Regen Biowellness to Re-Launch FDA Registered Patented Immune Booster ImmunaZin(TM) To Significantly Increase Revenues

By ACCESSWIRE ACCESSWIRE • 07-12-2022

The Former President of Loreal and Emergents Current Chairman of the Board and Soon to be Chief Executive Officer Jim Morrison to Appear on the Digital Stock & Investment News Network Rich TV Live

By ACCESSWIRE ACCESSWIRE • 08-10-2022

Emergent Executes Letter of Intent to Partner with Lumina to Commence its "Content Based Marketing" Initiative Through Influencers

By ACCESSWIRE ACCESSWIRE • 11-23-2022

Emergent Announces Letter of Intent to Partner with Clicktivated, the First and Only Fully Clickable Livestream Video to Create "Shoppable Content," Entering the $20 Billion Live Streaming E-Commerce Marketplace

By ACCESSWIRE ACCESSWIRE • 12-13-2022

Emergent Announces New Wholistic Re-Branding of all Products

By ACCESSWIRE ACCESSWIRE • 07-28-2022

(EMGE) Emergent Health Enters Acquisition Talks with Revenue-Producing Medical Company

By ACCESSWIRE ACCESSWIRE • 02-17-2023

Former L'Or�al President Jim Morrison, Chief Executive Officer of Emergent Health Corp. Reports Revenues of $185,471 for the Quarter Ended September 30, 2022, as Compared to $ 28,082 for the Quarter Ended September 30, 2021, an increase of over 600%

By ACCESSWIRE ACCESSWIRE • 11-21-2022

Emergent Acquires Evolutionary Biologics, Former L'Or�al President Jim Morrison to Become Full Time CEO of Emergent Effective August 15, 2022

By ACCESSWIRE ACCESSWIRE • 08-09-2022

Emergent's Pending Acquisition "Evolutionary Biologics" Engages "Aesthetics By Design" to Market, Sell and Distribute Regenerative Medicine Products Produced by Evolutionary Biologics with the Initial Focus Being Exo Elixir(TM)

By ACCESSWIRE ACCESSWIRE • 07-26-2022

Emergent Projects $3.5 Million in Revenues With Acquisition of Nanosthetic Corp. Fueling Evolutionary Biologics

By ACCESSWIRE ACCESSWIRE • 02-07-2023